New Mexico blood cancer patients now have options thanks to a new treatment
A groundbreaking treatment is transforming the approach to blood cancer care in New Mexico, with UNM Comprehensive Cancer Center now offering allogeneic transplants.
Dr. Matthew Fero, the director of the UNM Bone Marrow Transplant and Cell Therapy Program, has been instrumental in bringing this procedure to the center. “An allogeneic transplant, which uses stem cells from a donor, has the potential to eradicate disease in the bone marrow,” said Dr. Fero. “It also provides a new immune system to the patient that can target and eliminate any residual leukemia.”
Previously, blood cancer patients could only receive autologous transplants, which use their own stem cells. This limitation meant that patients needing allogeneic transplants had to travel out of state for treatment. Ana Aguilera, diagnosed with Acute Lymphoblastic Leukemia in May 2021, was among those who had to seek care elsewhere. After traveling to Phoenix in July 2022 and finding a donor from Brazil, Aguilera’s cancer relapsed. However, with the introduction of allogeneic transplants at the UNM Comprehensive Cancer Center, Aguilera was able to return for a second attempt. This time, her 22-year-old son was the match.
Aguilera’s treatment was successful, and she has been cancer-free for a year. Since the procedure’s introduction at the UNM Comprehensive Cancer Center, more than half a dozen allogeneic transplants have been performed, providing new hope for local patients.
The UNM Comprehensive Cancer Center is the sole National Cancer Institute-designated Cancer Center within a 500-mile radius, offering access to a wide range of specialized cancer care professionals. The Lobo Cancer Challenge, an annual event supporting patient care, research, and innovative treatments like allogeneic transplants, will be held on Saturday, September 28. KOAT proudly sponsors the event, which raises crucial funds for the cancer center. To donate or register, click here.
